Granules Pharma gets six observations from USFDA; Stock under pressure

25 Jul 2022 , 09:20 AM

Granules India Limited has informed that the USFDA has concluded an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company.

The mentioned foreign subsidiary is located in Chantilly, Virginia, the USA and observation was held on July 22, 2022 with six (6) observations. 

Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period, the company said in a filing statement.

At around 9:19 AM, Granules India was trading at Rs300.50 per share down by Rs2.4 or 0.79% from its previous closing of Rs302.90 per share on the BSE.